In addition, the dual-targeting NP delivery system tLyP-1-HFt-PTX NPs was also developed which not only improved tumor penetration through an NRP-1–dependent internalization pathway but also bound to tumor cells by interacting with TfR1. The gene discussed is TFRC; the disease is neoplasm.